A Randomized Trial of Exparel vs Saline in Opioid Reduction of Pain Management Following Lumbar Spine Surgeries. (Exparel)
A Randomized Controlled Trial of the Effect of Liposomal Bupivacaine (Exparel) When Compared to Saline Control in Reducing Opioid Utilization for Pain Management in Postoperative Lumbar Spine Surgeries.
Sponsor: University of Missouri-Columbia
A PHASE4 clinical study on Lumbar Spine Degeneration, this trial is completed. The trial is conducted by University of Missouri-Columbia and has accumulated 8 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jul 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Feb 2023 — Jul 2023 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Nov 2021 — Feb 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Apr 2021 — Nov 2021 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Missouri-Columbia
For direct contact, visit the study record on ClinicalTrials.gov .